Natural antioxidant therapy for patients with hemolytic anemia.

INDIAN PEDIATRICS 618 VOLUME 42__JUNE 17, 2005 arbitrary endpoint to evaluate the success of the WGJ therapy to decrease transfusion requirements in the study patients. Using their definition of success (>25% reduction of blood transfused compared to the pre-WGJ period), they reasoned that 50% of the patients responded to the WGJ therapy. Using the data they provided in the table in the paper, we performed relevant statistical analyses on the entire cohort to evaluate the effects of WGJ on the total amount of blood transfused and the mean interval between transfusions. We found that WGJ therapy decreased the total volume of blood transfused and increased the intervals between blood transfusions of the entire study cohort (Table I). More importantly, the blood transfusion requirements and intervals between transfusions of the post-WGJ therapy